NEW YORK (GenomeWeb) – Hologic said today that the US Food and Drug Administration has given it 510(k) clearance to market the Aptima Herpes Simplex Virus 1 & 2 molecular assay on its fully automated Panther system.

The assay, a nucleic acid amplification test used in conjunction with swab specimens from anogenital skin lesions, can be used to qualitatively detect and differentiate between HSV-1 and HSV-2. Clinicians collect samples using a new Aptima Multitest Swab Specimen Collection Kit or commercially available viral transport media.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.